Cancer is normally not hereditary, but a susceptibility that runs in the family causes approximately 5–10% of all cancers. Moreover, nearly all cancers have been found to have rare hereditary forms. Hereditary susceptibility is most commonly identified in breast and ovarian cancer and in families susceptible to colorectal cancer.

If a person is observed to have a hereditary susceptibility to cancer, Docrates Cancer Center can customise a personal monitoring programme for them.

Docrates is the first in Finland to offer Color’s hereditary cancer risk test based on a saliva sample. The Color Test analyses 30 genes which are known to be associated with hereditary susceptibility to cancer. The gene analysis is carried out in the United States and the results will be available in 3 to 6 weeks. Consider the test if there have been many cases of cancer in your family and you are worried about your potential cancer risk. At Docrates, we offer Color’s genetic risk test in connection with an appointment with a specialist in medical genetics.

Please contact us for more information. Tel. +358 10 773 2000.

Read more about the subject:

Press release on Color’s genetic risk test | Information about assessment of genetic risk for breast cancer

Why come to Docrates Cancer Center?

  • No waiting times: top cancer experts and effective treatments without delay
  • Individual care: you have your own care team - your doctor and your nurse
  • Front line cancer treatment: latest medical technology combined with proven expertise in cancer care
  • Experience in treating international patients: patients from over 50 countries, multilingual personnel
Contact us! +358 10 773 2000 (Mon-Thu 8 am-6 pm, Fri 8 am-4 pm, GMT +2)